Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Sepsis initiative 'too risky' for ICU

  • Comment
Tight glycaemic control (TGC) therapy is not viable in intensive care units, because of the associated risk to patient safety, according to nurse researchers.

Tight glycaemic control (TGC) therapy is not viable in intensive care units, because of the associated risk to patient safety, according to nurse researchers.

A six-month pilot study at London's Royal Free Hampstead NHS Trust tested whether TGC, using established control measures of 4.4 and 6.1 mmol/l, could be safely achieved in the unit.

Previous research has suggested continuous monitoring of blood sugar in ICU could reduce the risk of sepsis related death.

But lead author Carol Ball, nurse consultant in critical care, told NT that, while the Royal Free team was successful in maintaining TGC in patients, the pilot had revealed several areas of 'unacceptable risks'.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.